• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯烷基胺在体外对[3H]色胺与大鼠脑膜结合的抑制作用中的结构关系。

Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.

作者信息

Martin L L, Roland D M, Neale R F, Wood P L

出版信息

Eur J Pharmacol. 1986 Dec 2;132(1):53-5. doi: 10.1016/0014-2999(86)90008-7.

DOI:10.1016/0014-2999(86)90008-7
PMID:3816964
Abstract

The ability of various phenylalkylamines to inhibit the binding of [3H]tryptamine to rat frontal/parietal cortical membranes was examined in vitro. Affinity for [3H]tryptamine binding sites improved as the alkyl side chain was extended to include four carbons or when a methoxy group was added at the para position of the ring. One compound, p-methoxyphenylpropylamine (IC50 = 3.6 nM), was as potent as unlabelled tryptamine as a displacing agent. Based on the unique structure-activity relationship obtained, it appears that [3H]tryptamine binding sites do not mediate the actions of phenethylamines on serotonin uptake or release.

摘要

在体外研究了各种苯烷基胺抑制[3H]色胺与大鼠额叶/顶叶皮质膜结合的能力。随着烷基侧链延长至包含四个碳原子或在环的对位添加甲氧基,对[3H]色胺结合位点的亲和力增强。一种化合物,对甲氧基苯丙胺(IC50 = 3.6 nM),作为置换剂与未标记的色胺一样有效。基于所获得的独特构效关系,[3H]色胺结合位点似乎并不介导苯乙胺对5-羟色胺摄取或释放的作用。

相似文献

1
Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.苯烷基胺在体外对[3H]色胺与大鼠脑膜结合的抑制作用中的结构关系。
Eur J Pharmacol. 1986 Dec 2;132(1):53-5. doi: 10.1016/0014-2999(86)90008-7.
2
Biochemical characterization of [3H]tryptamine binding sites from rat brain.
Biochem Int. 1989 Jan;18(1):227-33.
3
[3H]tryptamine binding sites of rat cerebral cortex: pharmacological profile and plasticity.
Neuropharmacology. 1987 Aug;26(8):1093-7. doi: 10.1016/0028-3908(87)90253-x.
4
Autoradiographic localization and pharmacology of unique [3H]tryptamine binding sites in rat brain.大鼠脑中独特的[3H]色胺结合位点的放射自显影定位及药理学研究
Neuroscience. 1986;17(1):263-73. doi: 10.1016/0306-4522(86)90241-1.
5
Characterization of [3H]tryptamine binding sites in brain.
Eur J Pharmacol. 1983 Nov 11;95(1-2):31-9. doi: 10.1016/0014-2999(83)90264-9.
6
Temperature-sensitive high affinity [3H]tryptamine binding sites in rat brain.
Life Sci. 1986 Apr 7;38(14):1331-7. doi: 10.1016/0024-3205(86)90428-5.
7
The [3H]tryptamine receptor in human brain: kinetics, distribution, and pharmacologic profile.
J Neurochem. 1994 Sep;63(3):1052-9. doi: 10.1046/j.1471-4159.1994.63031052.x.
8
Unique [3H]tryptamine binding sites in rat brain: distribution and pharmacology.
Arch Int Pharmacodyn Ther. 1984 Apr;268(2):194-201.
9
Characterization and quantitative autoradiography of [3H]tryptamine binding sites in rat brain.大鼠脑中[3H]色胺结合位点的表征及定量放射自显影
Brain Res. 1986 Feb 26;366(1-2):72-88. doi: 10.1016/0006-8993(86)91282-5.
10
Down-regulation of tryptamine receptors following chronic administration of clorgyline.长期服用氯吉兰后色胺受体的下调。
Brain Res. 1987 Sep 1;419(1-2):239-43. doi: 10.1016/0006-8993(87)90589-0.

引用本文的文献

1
Trace amine-associated receptor 1-Family archetype or iconoclast?痕量胺相关受体1——家族原型还是叛逆者?
Pharmacol Ther. 2007 Dec;116(3):355-90. doi: 10.1016/j.pharmthera.2007.06.007. Epub 2007 Jul 17.
2
Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.长期服用吗茚酮后色胺结合位点的下调。与多巴胺和5-羟色胺受体反应的比较。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):366-71. doi: 10.1007/BF00167036.
3
Binding sites for brain trace amines.
脑痕量胺的结合位点。
Cell Mol Neurobiol. 1989 Sep;9(3):297-311. doi: 10.1007/BF00711411.
4
The structure-activity relationship of inhibitors of serotonin uptake and receptor binding.血清素摄取抑制剂与受体结合的构效关系。
J Comput Aided Mol Des. 1991 Oct;5(5):441-53. doi: 10.1007/BF00125664.